Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM

  1. Maron, M.S.
  2. Masri, A.
  3. Nassif, M.E.
  4. Barriales-Villa, R.
  5. Abraham, T.P.
  6. Arad, M.
  7. Cardim, N.
  8. Choudhury, L.
  9. Claggett, B.
  10. Coats, C.J.
  11. Düngen, H.-D.
  12. Garcia-Pavia, P.
  13. Hagège, A.A.
  14. Januzzi, J.L.
  15. Kulac, I.
  16. Lee, M.M.Y.
  17. Lewis, G.D.
  18. Ma, C.-S.
  19. Michels, M.
  20. Oreziak, A.
  21. Owens, A.T.
  22. Spertus, J.A.
  23. Solomon, S.D.
  24. Tfelt-Hansen, J.
  25. van Sinttruije, M.
  26. Veselka, J.
  27. Watkins, H.C.
  28. Jacoby, D.L.
  29. Heitner, S.B.
  30. Kupfer, S.
  31. Malik, F.I.
  32. Meng, L.
  33. Wohltman, A.
  34. Olivotto, I.
  35. Show all authors +
Journal:
Journal of the American College of Cardiology

ISSN: 1558-3597,  0735-1097

Year of publication: 2024

Issue Title: Special Focus Issue: Hypertrophic Cardiomyopathy

Volume: 84

Issue: 19

Pages: 1821-1831

Type: Article

DOI: 10.1016/J.JACC.2024.09.003 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus